2009 (118)
2010 (83)
2011 (69)
2014 (120)
2019 (209)
2024 (304)
2025 (14)
相当于500多万人民币
Adaptimmune is launching Tecelra — a one-time treatment — at a list price of $727,000, the most expensive per-dose cost of any cellular medicine for cancer in the U.S.
一批准国内就报道了: